ArticleEJNMMI research2020

Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2.

Anja C L Mortensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.